HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer
A phase 3 trial of Tamoxifen, Triptorelin, Letrozole and Zoledronic acid in Breast cancer, run by National Cancer Institute, Naples, with a status the registry has not verified recently.
Overview
HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer is a phase 3 interventional study registered as NCT00412022 by National Cancer Institute, Naples, with 1294 participants planned, started 2004-03 and due to reach its primary completion in 2024-11. Interventions recorded: tamoxifen, triptorelin, letrozole, zoledronic acid. Conditions recorded: Breast Cancer.
Linked to the drug Triptorelin because the registry names it among its interventions and Breast cancer among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialTriptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
Shares Triptorelin, Tamoxifen, Breast cancer (all types) and the tag pipeline.
- TrialIbandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer
Shares Zoledronic acid, Breast cancer (all types) and the tag pipeline.
- TrialEfficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast Cancer
Shares Tamoxifen, Breast cancer (all types) and the tag pipeline.
- TrialEffect of Triptorelin (Decapeptyl®) 22.5 mg on Two Biomarkers in Patients With Advanced Prostate Cancer
Shares Triptorelin and the tag pipeline.
- TrialTriptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer
Shares Triptorelin and the tag pipeline.
- TrialCombination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer
Shares Tamoxifen, Breast cancer (all types) and the tag pipeline.
- TrialComparison of Ibandronate - Zoledronate Regarding Nephrotoxicity in Multiple Myeloma
Shares Zoledronic acid and the tag pipeline.
- TrialInvestigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer
Shares Tamoxifen, Breast cancer (all types) and the tag pipeline.